Thrivent Financial for Lutherans’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.86M | Buy |
26,847
+8,538
| +47% | +$2.81M | 0.02% | 729 |
|
|
2025
Q4 | $6.42M | Sell |
18,309
-1,586
| -8% | -$536K | 0.01% | 845 |
|
|
2025
Q3 | $6.43M | Buy |
19,895
+2,202
| +12% | +$685K | 0.01% | 765 |
|
|
2025
Q2 | $6.87M | Sell |
17,693
-3,422
| -16% | -$1.38M | 0.02% | 699 |
|
|
2025
Q1 | $9.17M | Sell |
21,115
-279,169
| -93% | -$112M | 0.02% | 640 |
|
|
2024
Q4 | $111M | Sell |
300,284
-6,545
| -2% | -$2.74M | 0.21% | 100 |
|
|
2024
Q3 | $160M | Sell |
306,829
-6,912
| -2% | -$3.69M | 0.3% | 63 |
|
|
2024
Q2 | $170M | Sell |
313,741
-4,173
| -1% | -$2.21M | 0.34% | 47 |
|
|
2024
Q1 | $165M | Buy |
317,914
+64,728
| +26% | +$32.2M | 0.33% | 59 |
|
|
2023
Q4 | $119M | Sell |
253,186
-10,304
| -4% | -$4.76M | 0.26% | 93 |
|
|
2023
Q3 | $115M | Buy |
263,490
+192
| +0.1% | +$87.1K | 0.27% | 89 |
|
|
2023
Q2 | $117M | Sell |
263,298
-193,150
| -42% | -$89.1M | 0.27% | 90 |
|
|
2023
Q1 | $210M | Sell |
456,448
-35,690
| -7% | -$17M | 0.51% | 22 |
|
|
2022
Q4 | $252M | Buy |
492,138
+21,014
| +4% | +$10.7M | 0.65% | 13 |
|
|
2022
Q3 | $214M | Buy |
471,124
+63,067
| +15% | +$30.2M | 0.59% | 17 |
|
|
2022
Q2 | $197M | Sell |
408,057
-75,535
| -16% | -$37.4M | 0.52% | 21 |
|
|
2022
Q1 | $238M | Buy |
483,592
+33,907
| +8% | +$15.5M | 0.46% | 29 |
|
|
2021
Q4 | $208M | Buy |
449,685
+2,465
| +0.6% | +$1.04M | 0.4% | 46 |
|
|
2021
Q3 | $167M | Buy |
447,220
+171,891
| +62% | +$65.3M | 0.34% | 59 |
|
|
2021
Q2 | $105M | Buy |
275,329
+5,547
| +2% | +$2.12M | 0.21% | 118 |
|
|
2021
Q1 | $96.8M | Buy |
269,782
+57,980
| +27% | +$18.6M | 0.21% | 111 |
|
|
2020
Q4 | $68M | Buy |
211,802
+26,396
| +14% | +$8.1M | 0.16% | 160 |
|
|
2020
Q3 | $49.8M | Buy |
185,406
+85,013
| +85% | +$22.9M | 0.13% | 187 |
|
|
2020
Q2 | $26.3M | Buy |
100,393
+84,038
| +514% | +$22.4M | 0.08% | 289 |
|
|
2020
Q1 | $3.71M | Sell |
16,355
-42,702
| -72% | -$11.6M | 0.01% | 732 |
|
|
2019
Q4 | $17.8M | Buy |
59,057
+27,691
| +88% | +$7.62M | 0.05% | 411 |
|
|
2019
Q3 | $7.53M | Buy |
31,366
+1,065
| +4% | +$292K | 0.02% | 574 |
|
|
2019
Q2 | $8.55M | Buy |
30,301
+1,770
| +6% | +$484K | 0.03% | 564 |
|
|
2019
Q1 | $8.19M | Sell |
28,531
-10,684
| -27% | -$3.09M | 0.03% | 545 |
|
|
2018
Q4 | $10.3M | Sell |
39,215
-5,966
| -13% | -$1.64M | 0.04% | 441 |
|
|
2018
Q3 | $12.4M | Sell |
45,181
-2,808
| -6% | -$729K | 0.04% | 439 |
|
|
2018
Q2 | $11.4M | Sell |
47,989
-29,891
| -38% | -$6.92M | 0.04% | 461 |
|
|
2018
Q1 | $17.1M | Buy |
77,880
+49,225
| +172% | +$11.6M | 0.06% | 328 |
|
|
2017
Q4 | $6.45M | Sell |
28,655
-92
| -0.3% | -$19.6K | 0.02% | 573 |
|
|
2017
Q3 | $5.46M | Sell |
28,747
-825
| -3% | -$157K | 0.02% | 584 |
|
|
2017
Q2 | $5.56M | Buy |
29,572
+3,920
| +15% | +$704K | 0.02% | 540 |
|
|
2017
Q1 | $4.24M | Buy |
25,652
+8,880
| +53% | +$1.41M | 0.02% | 622 |
|
|
2016
Q4 | $2.41M | Buy |
16,772
+4,702
| +39% | +$630K | 0.01% | 800 |
|
|
2016
Q3 | $1.51M | Buy |
12,070
+4,000
| +50% | +$516K | 0.01% | 966 |
|
|
2016
Q2 | $1.06M | Buy |
8,070
+380
| +5% | +$52K | 0.01% | 1073 |
|
|
2016
Q1 | $1.07M | Buy |
7,690
+450
| +6% | +$60.1K | 0.01% | 1053 |
|
|
2015
Q4 | $1.01M | Buy |
7,240
+40
| +0.6% | +$5.51K | ﹤0.01% | 1064 |
|
|
2015
Q3 | $1.01M | Buy |
7,200
+300
| +4% | +$45.1K | 0.01% | 959 |
|
|
2015
Q2 | $1.13M | Buy |
6,900
+300
| +5% | +$47.9K | 0.01% | 789 |
|
|
2015
Q1 | $1.02M | Sell |
6,600
-93,350
| -93% | -$13.3M | 0.01% | 838 |
|
|
2014
Q4 | $12.6M | Sell |
99,950
-6,200
| -6% | -$766K | 0.07% | 282 |
|
|
2014
Q3 | $12.7M | Buy |
106,150
+36,800
| +53% | +$4.22M | 0.07% | 264 |
|
|
2014
Q2 | $7.46M | Buy |
69,350
+32,900
| +90% | +$3.39M | 0.04% | 385 |
|
|
2014
Q1 | $3.63M | Sell |
36,450
-14,350
| -28% | -$1.3M | 0.02% | 488 |
|
|
2013
Q4 | $4.69M | Buy |
50,800
+2,400
| +5% | +$213K | 0.03% | 452 |
|
|
2013
Q3 | $4.05M | Buy |
48,400
+38,000
| +365% | +$3.26M | 0.03% | 470 |
|
|
2013
Q2 | $851 | Buy |
+10,400
| New | +$778K | 0.01% | 740 |
|
Other funds holding ELV
VCM
VPM
Thrivent Financial for Lutherans's ELV Position: Q1 2026 in Review
Thrivent Financial for Lutherans increased its Elevance Health (ELV) stake by 47% in Q1 2026, buying an estimated $2.81M and bringing the position to 26,847 shares worth $7.86M. The position accounts for 0.02% of the portfolio, ranked #729.
Thrivent Financial for Lutherans first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $252M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Thrivent Financial for Lutherans held 26,847 shares of Elevance Health worth $7.86M as of Q1 2026.
- Thrivent Financial for Lutherans bought 8,538 Elevance Health shares in Q1 2026, an estimated $2.81M.
- Elevance Health made up 0.02% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #729 holding.
- Thrivent Financial for Lutherans first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Thrivent Financial for Lutherans's Elevance Health position peaked at $252M in Q4 2022.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.